{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:54:43Z","timestamp":1793199283178,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10554-020-01823-7","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T09:02:49Z","timestamp":1588928569000},"page":"1333-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping"],"prefix":"10.1007","volume":"36","author":[{"given":"Patricia","family":"R\u00e9ant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Testet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Rooryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"de-Pr\u00e9cigout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Peyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Cochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Lafitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM et al (1967) Enzymatic defect in Fabry\u2019s disease Ceramidetrihexosidase deficiency. N Engl J Med 276:1163\u20131167","journal-title":"N Engl J Med"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435","journal-title":"Lancet"},{"key":"1823_CR3","first-page":"1004","volume":"125","author":"G Houge","year":"2005","unstructured":"Houge G, Skarbovik AJ (2005) Fabry disease: a diagnostic and therapeutic challenge. Tidsskr Nor Laegeforen 125:1004\u20131006","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1823_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30","journal-title":"Orphanet J Rare Dis"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","volume":"57","author":"MR Patel","year":"2011","unstructured":"Patel MR, Cecchi F, Cizmarik M et al (2011) Cardiovascular events in patients with Fabry disease natural history data from the fabry registry. J Am Coll Cardiol 57:1093\u20131099","journal-title":"J Am Coll Cardiol"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek S, Patel MR, Banikazemi M et al (2009) Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med 11:790\u2013796","journal-title":"Genet Med"},{"key":"1823_CR7","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.108.841494","volume":"119","author":"BL Thurberg","year":"2009","unstructured":"Thurberg BL, Fallon JT, Mitchell R et al (2009) Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy. Circulation 119:2561\u20132567","journal-title":"Circulation"},{"key":"1823_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/hrt.2006.104026","volume":"94","author":"DA Hughes","year":"2008","unstructured":"Hughes DA, Elliott PM, Shah J (2008) Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo controlled clinical trial of agalsidase alfa. Heart 94:153\u2013158","journal-title":"Heart"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.echo.2018.01.016","volume":"31","author":"DF Yeung","year":"2018","unstructured":"Yeung DF, Sirrs S, Tsang MYC et al (2018) Echocardiographic assessment of patients with Fabry disease. J Am Soc Echocardiogr 31:639\u2013649","journal-title":"J Am Soc Echocardiogr"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.echo.2013.09.005","volume":"26","author":"M Shanks","year":"2013","unstructured":"Shanks M, Thompson RB, Paterson ID et al (2013) Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr 26:1407\u20131414","journal-title":"J Am Soc Echocardiogr"},{"key":"1823_CR11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/echo.12216","volume":"30","author":"MC Saccheri","year":"2013","unstructured":"Saccheri MC, Cianciulli TF, Lax JA et al (2013) Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography 30:1069\u20131077","journal-title":"Echocardiography"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/heartjnl-2015-308494","volume":"102","author":"R Kozor","year":"2016","unstructured":"Kozor R, Grieve SM, Tchan MC et al (2016) Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR. Heart 102:298\u2013302","journal-title":"Heart"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/10976640600605002","volume":"8","author":"JC Moon","year":"2006","unstructured":"Moon JC, Sheppard M, Reed E et al (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8:479","journal-title":"J Cardiovasc Magn Reson"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12968-016-0233-6","volume":"18","author":"DP Deva","year":"2016","unstructured":"Deva DP, Hanneman K, Li Q et al (2016) Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease. J Cardiovasc Magn Reson 18:14","journal-title":"J Cardiovasc Magn Reson"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","volume":"114","author":"J Kramer","year":"2014","unstructured":"Kramer J, Niemann M, Stork S et al (2014) Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. Am J Cardiol 114:895\u2013900","journal-title":"Am J Cardiol"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","volume":"16","author":"S Pica","year":"2014","unstructured":"Pica S, Sado DM, Maestrini V et al (2014) Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 16:99","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"1823_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","volume":"65","author":"C Whybra","year":"2004","unstructured":"Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65(4):299\u2013307","journal-title":"Clin Genet"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0025-6196(12)60540-0","volume":"60","author":"R Nishimura","year":"1985","unstructured":"Nishimura R, Miller FJ, Callahan M et al (1985) Doppler echocardiography: theory, instrumentation technique and application. Mayo Clin Proc 60:321\u2013343","journal-title":"Mayo Clin Proc"},{"key":"1823_CR19","first-page":"271","volume":"53","author":"A Tajik","year":"1978","unstructured":"Tajik A, Seward J, Hagler D et al (1978) Two dimensional real-time ultrasonic imaging of the heart and great vessels: technique, image orientation, structure identification and validation. Mayo Clin Proc 53:271\u2013303","journal-title":"Mayo Clin Proc"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2015","unstructured":"Lang RM, Bierig M, Devereux RB et al (2015) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","volume":"22","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107\u2013133","journal-title":"J Am Soc Echocardiogr"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685\u2013713","journal-title":"J Am Soc Echocardiogr"},{"key":"1823_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12968-015-0114-4","volume":"17","author":"R Kozor","year":"2015","unstructured":"Kozor R, Callaghan F, Tchan M et al (2015) A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease. J Cardiovasc Magn Reson 17:22","journal-title":"J Cardiovasc Magn Reson"},{"key":"1823_CR24","volume-title":"Principles of exercise testing and interpretation","author":"K Wasserman","year":"2004","unstructured":"Wasserman K, Hansen JE, Sue D et al (2004) Principles of exercise testing and interpretation, 4th edn. Lippincott Williams and Wilkins, Philadelphia","edition":"4"},{"key":"1823_CR25","doi-asserted-by":"publisher","first-page":"W97","DOI":"10.2214\/AJR.08.1201","volume":"192","author":"F De Cobelli","year":"2009","unstructured":"De Cobelli F, Esposito A, Belloni E et al (2009) Delayed-enhanced cardiac MRI for differentiation of Fabry\u2019s disease from symmetric hypertrophic cardiomyopathy. Am J Roentgenol 192:W97\u2013102","journal-title":"Am J Roentgenol"},{"key":"1823_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98:1442\u20131448","journal-title":"Heart"},{"key":"1823_CR27","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/eurheartj\/eht098","volume":"34","author":"J Kr\u00e4mer","year":"2013","unstructured":"Kr\u00e4mer J, Niemann M, Liu D et al (2013) Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J 34:1587\u20131596","journal-title":"Eur Heart J"},{"issue":"6","key":"1823_CR28","first-page":"I15","volume":"87","author":"JN Cohn","year":"1993","unstructured":"Cohn JN, Johnson GR, Shabetai R et al (1993) Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87(6):I15\u201316","journal-title":"Circulation"},{"key":"1823_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ahj.2003.07.014","volume":"147","author":"R Arena","year":"2004","unstructured":"Arena R, Myers J, Aslam SS et al (2004) Peak VO2 and VE\/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 147:354\u2013360","journal-title":"Am Heart J"},{"key":"1823_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1445-5994.2008.01669.x","volume":"38","author":"T Lobo","year":"2008","unstructured":"Lobo T, Morgan J, Bjorksten A et al (2008) Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. Intern Med J 38:407\u2013414","journal-title":"Intern Med J"},{"key":"1823_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pcad.2017.03.002","volume":"60","author":"J Myers","year":"2017","unstructured":"Myers J, Kaminsky L, Lima R et al (2017) A reference equation for normal standards for VO2 max: analysis from the fitness registry and the importance of exercise national database (FRIEND Registry). Prog Cardiovasc Dis 60:21\u201329","journal-title":"Prog Cardiovasc Dis"},{"key":"1823_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1183\/09031936.00074208","volume":"33","author":"B Koch","year":"2008","unstructured":"Koch B, Schaper C, Ittermann T et al (2008) Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J 33:389\u2013397","journal-title":"Eur Respir J"},{"key":"1823_CR33","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1136\/heartjnl-2019-315229","volume":"105","author":"R Vijapurapu","year":"2019","unstructured":"Vijapurapu R, Geberhiwot T, Jovanovic A et al (2019) Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy. Heart 105:1825\u20131831","journal-title":"Heart"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-020-01823-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:45:40Z","timestamp":1722869140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-020-01823-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s10554-020-01823-7","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"26 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Financial support of Shire\u00ae France for data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}